Endometrial effects of RU486 in primates—Antiproliferative action despite signs of estrogen action and increased cyclin-B expression
- 1 October 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 59 (2) , 179-190
- https://doi.org/10.1016/s0960-0760(96)00113-6
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta)Journal of Clinical Endocrinology & Metabolism, 1994
- The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical studyJournal of Clinical Endocrinology & Metabolism, 1993
- Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeysContraception, 1993
- Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatmentEndocrinology, 1993
- Effects of continuous treatment with low dose mifepristone throughout one menstrual cycleHuman Reproduction, 1993
- Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential**Supported by the San Diego Reproductive Medicine Research and Educational Foundation, San Diego, California and conducted, in part, by the Mellon Foundation, New York, New York.Fertility and Sterility, 1992
- Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: A potential new contraceptive strategyAmerican Journal of Obstetrics and Gynecology, 1992
- Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeysFertility and Sterility, 1989
- Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen induced endometrial proliferationContraception, 1989
- Effects of an Antiprogesterone (RU486) on the Hypothalamic-Hypophyseal-Ovarian-Endometrial Axis During the Luteal Phase of the Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1988